Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Manahawkin › NPI 1841510849
Hospital

Meridian Hospitals Corporation

Meridian Hospitals Corporation was paid $3.08M by Medicaid between Jan 2018 and Sep 2018, across 129 billing codes. Its largest line is 99283, emergency room visit (moderate) — 27% of everything it billed.

33Billing provider infoMERIDIAN HOSPITALS CORPORATION
MANAHAWKIN, NJ 08050
33aNPI1841510849assigned 06/02/2010
28Total paid$3.08M
24GClaims43,857
24DCodes billed129
24AFirst – last monthJan 2018 – Sep 2018
Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#67 of 93
Median peer was paid$30.60M
This provider vs. median0.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201843,857$3.08M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 27% 2,533 2,413 $842K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 21% 1,620 1,515 $658K
99282 Emergency department visit for the evaluation and management, low to moderate severity 7.6% 1,132 1,084 $235K
G0378 Hospital observation service, per hour 6.8% 188 167 $209K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.9% 501 482 $150K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 4.1% 103 103 $127K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.6% 1,600 357 $112K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 3.3% 80 80 $101K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.6% 866 215 $51K
96375 Therapeutic injection; each additional sequential IV push 1.3% 446 334 $40K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.1% 1,021 932 $34K
95886 1.0% 83 83 $32K
117 more codes
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1.0% 289 $31K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 166 $26K
OP259 <1% 3,000 $21K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 2,692 $20K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 279 $20K
80053 Comprehensive metabolic panel <1% 2,431 $19K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 487 $19K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 15 $18K
70450 Computed tomography, head or brain; without contrast material <1% 344 $16K
OP279 <1% 1,256 $16K
92587 <1% 82 $15K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 287 $15K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 604 $14K
92557 <1% 45 $13K
71046 Radiologic examination, chest; 2 views <1% 907 $11K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 478 $10K
92567 <1% 104 $10K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 527 $10K
96361 Intravenous infusion, hydration; each additional hour <1% 280 $9K
36415 Collection of venous blood by venipuncture <1% 2,073 $9K
95819 <1% 12 $9K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 379 $9K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 460 $9K
81003 <1% 1,764 $8K
97010 <1% 1,110 $7K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 25 $6K
93971 <1% 35 $6K
77067 Screening mammography, bilateral, including computer-aided detection <1% 57 $6K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 149 $5K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 118 $5K
97162 <1% 63 $5K
71045 Radiologic examination, chest; single view <1% 322 $5K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 76 $5K
76830 Ultrasound, transvaginal <1% 88 $4K
OP379 <1% 136 $4K
84484 <1% 502 $4K
97161 <1% 59 $4K
OP272 <1% 340 $4K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 116 $3K
83690 <1% 823 $3K
81025 <1% 1,182 $3K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 50 $3K
85610 <1% 484 $3K
82550 <1% 296 $2K
OP710 <1% 122 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 682 $2K
73630 <1% 191 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 598 $2K
80048 Basic metabolic panel (calcium, ionized) <1% 293 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 90 $2K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 80 $2K
73610 <1% 149 $2K
73130 <1% 144 $2K
72125 Computed tomography, cervical spine; without contrast material <1% 27 $2K
85027 <1% 151 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 186 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 302 $1K
73030 <1% 86 $1K
73564 <1% 70 $1K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 113 $1K
J2704 Injection, propofol, 10 mg <1% 161 $1K
87040 <1% 179 $1K
J1644 Injection, heparin sodium, per 1000 units <1% 73 $1K
87088 <1% 319 $1K
85730 <1% 284 $1K
86901 <1% 146 $986.61
86900 <1% 146 $969.81
72110 <1% 44 $886.39
76775 <1% 14 $882.94
84443 Thyroid stimulating hormone (TSH) <1% 165 $878.54
83880 <1% 121 $869.24
86885 <1% 51 $811.56
J2060 Injection, lorazepam, 2 mg <1% 127 $802.11
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 13 $679.27
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 14 $679.27
73562 <1% 29 $671.76
74018 <1% 53 $632.10
83735 <1% 235 $623.35
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 536 $602.43
80061 Lipid panel <1% 59 $579.74
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 14 $516.22
90715 <1% 43 $474.57
87070 <1% 297 $455.85
96376 <1% 30 $440.91
73502 <1% 19 $440.80
72100 <1% 32 $420.44
J7050 Infusion, normal saline solution, 250 cc <1% 106 $414.84
83605 <1% 93 $386.53
84702 <1% 65 $382.23
73110 <1% 44 $323.25
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 122 $321.09
74021 <1% 66 $317.23
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 302 $290.38
85378 <1% 180 $266.01
99201 <1% 12 $246.00
82803 <1% 14 $225.05
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 335 $195.81
82150 <1% 43 $194.69
88313 <1% 101 $163.84
83789 <1% 13 $161.63
71100 <1% 13 $158.22
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 61 $150.56
87999 <1% 116 $119.87
88312 <1% 99 $116.38
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 12 $114.00
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 12 $114.00
J1170 Injection, hydromorphone, up to 4 mg <1% 147 $68.25
84100 <1% 44 $67.52
86308 <1% 12 $34.34
85651 <1% 13 $23.28
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 80 $14.04
87147 <1% 16 $12.65
J7030 Infusion, normal saline solution , 1000 cc <1% 26 $12.00
73140 <1% 15 $9.80
81002 <1% 12 $3.00
J7510 Prednisolone oral, per 5 mg <1% 15 $2.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCOYLE, JOSEPH (CEO)
Parent organizationMERIDIAN HOSPITALS CORPORATION